Cello Health BioConsulting
  • menu
  • Home
  • About us
    • Why We’re Different
    • Our Team
    • Mission, Vision & Values
  • Capabilities
    • Common Client Dilemmas
    • Opportunity Assessments
    • Opportunity Search and Evaluation
    • Portfolio and Platform Strategy
    • Business Development & Partnering Strategy
    • Market Access Strategy
    • Early Stage Strategy
  • Our Insights
    • News
    • Presentations
    • Testimonials
    • Events
  • Careers
    • Current Opportunities
    • A Day in the Life
    • Our Culture

Our Insights

Trends and Future Insights in the Immuno-Oncology Space

Trends and Future Insights in the Immuno-Oncology Space

Oncology | November 26, 2018
More +

Advanced Therapies in the CNS – Time to Get Smart

Advanced Therapies in the CNS – Time to Get Smart

CNS | October 16, 2018
More +

Pharma and Biotech M&A in Gene & Cell Therapy: What’s Next in Deal Making in the Emerging Advanced Therapeutics Space?

Pharma and Biotech M&A in Gene & Cell Therapy: What’s Next in Deal Making in the Emerging Advanced Therapeutics Space?

Gene & Cell Therapy | October 10, 2018
More +

Depression Rising (Again): Turning the Corner in Psychiatry’s Most Burdensome Disorder

Depression Rising (Again): Turning the Corner in Psychiatry’s Most Burdensome Disorder

CNS | Payer | June 21, 2018
More +

Here We Go Again? Payer Management of Me-Toos in the Modern Oncology Era

Here We Go Again? Payer Management of Me-Toos in the Modern Oncology Era

Oncology | Payer | April 12, 2018
More +

BISPECIFICS in Oncology and IO: Anything One Can Do, Can Two Do Better?

BISPECIFICS in Oncology and IO: Anything One Can Do, Can Two Do Better?

Oncology | February 14, 2018
More +

Defined Health Insight Series Briefing: Gene And Cell Therapies – It’s Show Time!

Defined Health Insight Series Briefing: Gene And Cell Therapies – It’s Show Time!

Gene & Cell Therapy | January 29, 2018
More +

New frontiers in COPD — what’s next on the treatment horizon?

New frontiers in COPD — what’s next on the treatment horizon?

Respiratory | October 18, 2017
More +

The Dash to Treat NASH, Looking Toward the Finish Line

The Dash to Treat NASH, Looking Toward the Finish Line

Nash/Fibrosis | Payer | August 23, 2017
More +

Cancer Progress Revisited: Making Sense and Cents of IO Combos and their Value

Cancer Progress Revisited: Making Sense and Cents of IO Combos and their Value

Oncology | June 27, 2017
More +

  1. ←
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. →

Search

Elsewhere

Let’s work together

Contact us

  • Cello Health BioConsulting
  • 25-B Hanover Road
  • Suite 320
  • Florham Park, NJ
  • 07932
  • USA
  • +1 973 292 5001
  •  
  • Part of Cello Health plc

    Follow us

    Cello Health BioConsulting

    ©2021 Defined Health, now known as Cello Health BioConsulting | Privacy policy.

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Defined Health, now known as Cello Health BioConsulting
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    3rd Party Cookies

    This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

    Keeping this cookie enabled helps us to improve our website.

    Please enable Strictly Necessary Cookies first so that we can save your preferences!